By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Catalyst Pharmaceutical Partners, Inc. 

355 Alhambra Circle, Suite 1500

Coral Gables  Florida  33134  U.S.A.
Phone: 305-529-2522 Fax: 305-529-0933


SEARCH JOBS


Industry
Pharmaceutical






Company News
Catalyst Pharmaceuticals (CPRX) To Present At The 18th Annual BIO CEO & Investor Conference 2/4/2016 7:55:46 AM
Catalyst Pharmaceuticals (CPRX) Completes NDA Submission To FDA For Firdapse For The Treatment Of Lambert-Eaton Myasthenic Syndrome And Congenital Myasthenic Syndromes 12/17/2015 7:59:30 AM
Catalyst Pharmaceuticals (CPRX) Announces Top-Line Results In Phase 1(B) Trial Of CPP-115 12/16/2015 8:02:45 AM
Catalyst Pharmaceuticals (CPRX) To Present At The 27th Annual Piper Jaffray Healthcare Conference 11/24/2015 9:58:39 AM
Catalyst Pharmaceuticals (CPRX) Announces Third Quarter 2015 Financial Results And Provides Corporate Update 11/10/2015 8:11:55 AM
Catalyst Pharmaceuticals (CPRX) To Hold Third Quarter Financial Results Conference Call And Webcast On Tuesday, November 10, 2015 11/4/2015 7:37:49 AM
Catalyst Pharmaceuticals (CPRX) Announces Poster Presentation At 62nd Annual Meeting Of The American Academy Of Child And Adolescent Psychiatry 10/27/2015 7:52:55 AM
Catalyst Pharmaceuticals (CPRX) To Present At 14th Annual BIO Investor Forum 10/19/2015 7:46:51 AM
Catalyst Pharmaceuticals (CPRX) Announces Notice Of Allowance Of A U.S. Patent Application For The Method Of Treating Tourette's Disorder With GABA-Aminotransferase Inactivators 10/13/2015 7:26:02 AM
Catalyst Pharmaceuticals (CPRX) Announces A Clinical Trial For Pediatric Patients With Congenital Myasthenic Syndromes 10/6/2015 7:19:41 AM
12345678910...
//-->